InventionMed S.A. (WSE:INM)
Poland
· Delayed Price · Currency is PLN 0.1774
-0.0008 (-0.45%)
At close: Mar 28, 2025
InventionMed Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 0.28 | 0 | 0 | 0.01 | 0.01 | Upgrade
|
| Revenue Growth (YoY) | 45810.74% | -85.12% | -61.10% | 100.96% | -87.32% | Upgrade
|
| Cost of Revenue | 0.18 | 0.01 | 0.01 | 0.01 | 0.03 | Upgrade
|
| Gross Profit | 0.1 | -0.01 | -0 | 0.01 | -0.03 | Upgrade
|
| Selling, General & Admin | 2.13 | 1.45 | 1.32 | 1.08 | 0.95 | Upgrade
|
| Other Operating Expenses | -0.41 | -1.4 | -0.6 | -0.47 | -0.51 | Upgrade
|
| Operating Expenses | 2.57 | 1.15 | 0.75 | 0.68 | 0.54 | Upgrade
|
| Operating Income | -2.47 | -1.17 | -0.75 | -0.67 | -0.57 | Upgrade
|
| Interest Expense | -1.54 | -0.82 | -0.33 | -0 | -0 | Upgrade
|
| Interest & Investment Income | 0 | - | - | - | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | - | -0 | -0.01 | - | -0.06 | Upgrade
|
| EBT Excluding Unusual Items | -4 | -1.99 | -1.1 | -0.67 | -0.63 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -21.12 | - | 0.2 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0.1 | 0.06 | - | - | Upgrade
|
| Pretax Income | -4 | -1.89 | -22.15 | -0.67 | -0.43 | Upgrade
|
| Income Tax Expense | - | - | - | - | 0.03 | Upgrade
|
| Net Income | -4 | -1.89 | -22.15 | -0.67 | -0.45 | Upgrade
|
| Net Income to Common | -4 | -1.89 | -22.15 | -0.67 | -0.45 | Upgrade
|
| Shares Outstanding (Basic) | 203 | 203 | 203 | 203 | 203 | Upgrade
|
| Shares Outstanding (Diluted) | 203 | 203 | 203 | 203 | 203 | Upgrade
|
| Shares Change (YoY) | - | - | - | - | 42.02% | Upgrade
|
| EPS (Basic) | -0.02 | -0.01 | -0.11 | -0.00 | -0.00 | Upgrade
|
| EPS (Diluted) | -0.02 | -0.01 | -0.11 | -0.00 | -0.00 | Upgrade
|
| Free Cash Flow | 0.7 | -14.88 | -6.36 | 4.54 | -4.91 | Upgrade
|
| Free Cash Flow Per Share | 0.00 | -0.07 | -0.03 | 0.02 | -0.02 | Upgrade
|
| Gross Margin | 35.13% | - | -58.84% | 50.23% | - | Upgrade
|
| Operating Margin | -889.34% | -192602.65% | -18565.76% | -6450.20% | -11018.33% | Upgrade
|
| Profit Margin | -1441.23% | -312258.35% | -545002.61% | -6450.38% | -8714.79% | Upgrade
|
| Free Cash Flow Margin | 250.42% | -2459759.83% | -156521.01% | 43450.64% | -94401.75% | Upgrade
|
| EBITDA | -1.62 | -0.07 | -0.72 | -0.61 | -0.47 | Upgrade
|
| D&A For EBITDA | 0.85 | 1.1 | 0.03 | 0.07 | 0.1 | Upgrade
|
| EBIT | -2.47 | -1.17 | -0.75 | -0.67 | -0.57 | Upgrade
|
| Revenue as Reported | 0.28 | 0 | 0 | 0.01 | 0.01 | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.